Inari Medical, Inc. revised revenue guidance for the year 2023. For the full year 2023, the company is raising revenue guidance to a range of $490 million to $493 million, an increase of $4.5 million at the midpoint from prior guidance range of $482 million to $492 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50 USD | -1.37% | +0.09% | -22.99% |
05-23 | Sector Update: Health Care Stocks Lower Thursday Afternoon | MT |
05-23 | Inari Medical Sues Imperative Care, Truvic Medical for Alleged Patent Infringement | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.99% | 2.91B | |
+75.69% | 12.57B | |
-24.68% | 7.34B | |
+6.22% | 6.61B | |
+12.58% | 5.39B | |
-16.63% | 4.84B | |
+26.90% | 4.53B | |
-21.14% | 3.91B | |
+47.42% | 2.37B | |
-0.37% | 2B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Revises Revenue Guidance for the Year 2023